BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1378346)

  • 1. Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Abdullah L; Zuniga J; Madison S; Maixner W
    Brain Res; 1992 May; 579(2):187-94. PubMed ID: 1378346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes.
    Suarez-Roca H; Maixner W
    Brain Res; 1992 May; 579(2):195-203. PubMed ID: 1378347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons.
    Suarez-Roca H; Maixner W
    Neurosci Lett; 1995 Jul; 194(1-2):41-4. PubMed ID: 7478208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.
    Cano G; Arcaya JL; Gómez G; Maixner W; Suarez-Roca H
    Neurochem Res; 1999 Oct; 24(10):1203-7. PubMed ID: 10492514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro.
    Ray NJ; Jones AJ; Keen P
    Br J Pharmacol; 1991 Apr; 102(4):797-800. PubMed ID: 1713104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers.
    Arcaya JL; Cano G; Gómez G; Maixner W; Suárez-Roca H
    Eur J Pharmacol; 1999 Jan; 366(1):27-34. PubMed ID: 10064148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways.
    Cabot PJ; Cramond T; Smith MT
    Pulm Pharmacol Ther; 1997 Aug; 10(4):215-21. PubMed ID: 9695145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine produces release of substance P-like immunoreactivity from guinea-pig central nervous system.
    Chahl LA
    Neurosci Lett; 1990 Oct; 118(1):88-90. PubMed ID: 1701871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.
    Vasko MR; Ono H
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):441-6. PubMed ID: 1701522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine and norepinephrine but not 5-hydroxytryptamine and gamma-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices.
    Pang IH; Vasko MR
    Brain Res; 1986 Jun; 376(2):268-79. PubMed ID: 2425894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P releases and augments the morphine-evoked release of adenosine from spinal cord.
    Cahill CM; White TD; Sawynok J
    Brain Res; 1997 Jun; 760(1-2):294-7. PubMed ID: 9237551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate analgesics inhibit substance P release from rat trigeminal nucleus.
    Jessell TM; Iversen LL
    Nature; 1977 Aug; 268(5620):549-51. PubMed ID: 18681
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of opioids and opioid peptide on the release of substance P-like material induced by tooth pulp stimulation in the trigeminal nucleus caudalis of the rabbit.
    Yonehara N; Shibutani T; Tsai HY; Inoki R
    Eur J Pharmacol; 1986 Oct; 129(3):209-16. PubMed ID: 2430813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
    Crain SM; Shen KF
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of morphine on cutaneous blood flow and substance P release evoked by electric stimulation of rat sciatic nerve].
    Chen JQ; Yonehara N; Imai Y; Xu WJ; Inoki R
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):355-7. PubMed ID: 1725470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of morphine on corneal-responsive neurons in rostral versus caudal regions of spinal trigeminal nucleus in the rat.
    Meng ID; Hu JW; Bereiter DA
    J Neurophysiol; 1998 May; 79(5):2593-602. PubMed ID: 9582231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of morphine on changes in cutaneous blood flow induced by antidromic stimulation of primary afferent fibers in the hind instep of rats.
    Yonehara N; Tang FD; Inoki R
    Jpn J Pharmacol; 1993 Sep; 63(1):53-8. PubMed ID: 7505859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.